Idorsia Ltd
Idorsia Ltd (IDRSF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
idrsf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Idorsia Ltd (IDRSF) measures how much investors pay for each dollar of the company's trailing earnings. IDRSF's current PE ratio of N/A is calculated by dividing its stock price of $5.75 by its TTM earnings per share of -$0.87.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Idorsia LtdYou IDRSF | $1.5B | N/A | — | -$0.87 |
 Arjo AB (publ) ARRJF | $891M | 25.18x | -20.3% | $1.23 |
 Ascletis Pharma Inc. ASCLF | $1.4B | N/A | — | -$0.36 |
 Basilea Pharmaceutica AG BPMUF | $806M | 15.24x | -51.8% | $3.29 |
 Valneva SE INRLF | $531M | N/A | — | -$0.68 |
 LifeTech Scientific Corporation LFTSF | $858M | 33.56x | +6.2% | $0.05 |
 Nanosonics Limited NNCSF | $619M | 52.39x | +65.8% | $0.07 |
Industry Average 4 peers with valid PE | — | 31.60x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.52 | — | |
2024-12-31 FY2024 | — | $-1.45 | — | |
2023-12-31 FY2023 | — | $-1.67 | — | |
2022-12-31 FY2022 | — | $-4.67 | — | |
2021-12-31 FY2021 | — | $-3.77 | — | |
2020-12-31 FY2020 | — | $-3.11 | — | |
2019-12-31 FY2019 | — | $-3.71 | — | |
2018-12-31 FY2018 | — | $-3.06 | — | |
2017-12-31 FY2017 | — | $-0.12 | — | |
2016-12-31 FY2016 | — | $-2.81 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Idorsia Ltd (IDRSF) measures how much investors pay for each dollar of the company's trailing earnings. IDRSF's current PE ratio of N/A is calculated by dividing its stock price of $5.75 by its TTM earnings per share of -$0.87.
Frequently asked questions
IDRSF pe ratio · 6 questionsIDRSF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $5.75 and TTM EPS of -$0.87. Data sourced from Financial Modeling Prep via IDRSF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Idorsia Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09